NCT04621045

Brief Summary

Individuals who are overweight/obese are more vulnerable to type 2 diabetes (T2D). Current evidence suggests that PA, even without dietary prescription, can be efficacious in preventing T2D. Yet most Americans, especially those who are overweight/obese, are not physically active. Socioenvironmental barriers to physical activity (PA) such as body image concerns and limited access to fitness facilities contribute to the low levels of PA observed in overweight/obese adults. Web-based PA programs have been developed to address these barriers, but the outcomes have been marginal. Qualitative studies suggest that individuals who are overweight/obese prefer PA programs that feature people they can relate to especially in body size, fitness status and age. Previously, the investigators have included these preferences in a technology-based Physical Activity for The Heart (PATH) intervention that leverages open source platforms, such as YouTube, to promote PA in any setting. In this application, the investigators propose to test the feasibility and preliminary efficacy of PATH in promoting PA and reducing cardiometabolic risk in adults who are overweight/obese and at high risk of diabetes. In Aim 1 the investigators will conduct a 12-week randomized clinical trial including 52 adults who are overweight/obese and at high risk of diabetes to assess the feasibility and acceptability of PATH. In Aim 2 investigators will examine the trend in PA and cardiometabolic risk change from baseline to post-intervention. This approach is innovative because it leverages open source technologies to provide low-cost, action-oriented PA resources that match the preferences of adults who are overweight/obese. This contribution will be significant because PATH could offer a convenient, enjoyable and scalable program that features "similar others" to promote PA in overweight/obese adults at high risk of diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 27, 2020

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 9, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 12, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2022

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2022

Enrollment Period

1.4 years

First QC Date

November 2, 2020

Last Update Submit

October 6, 2022

Conditions

Keywords

Physical activityWeb-basedYouTube

Outcome Measures

Primary Outcomes (3)

  • Recruitment feasibility

    Will be indicated by ability to recruit, screen, and enroll the target sample within 6 months of commencing recruitment, and retention of ≥80% of the sample.

    At the end of study approximately 48 weeks after commencement of the study

  • Feasibility of self-monitoring step count using wrist worn ActiGraph GT9X

    will be indicated by the proportion of the sample with ≥4days per week of valid Actigraph wear time (≥10hrs) during the entire course of the study.

    At the end of study approximately 52 weeks after commencement of the study

  • Acceptability of PATH intervention

    Will be indicated by utilization data that will be collected via Web analytics, and a post-intervention survey will assess the intervention acceptability.

    At the end of study approximately 52 weeks after commencement of the study

Secondary Outcomes (11)

  • Change from baseline in body mass index (BMI) at 12 weeks

    Post-intervention at 12 weeks

  • Change from baseline in body fat percentage at 12 weeks

    Post-intervention at 12 weeks

  • Change from baseline in waist circumference at 12 weeks

    Post-intervention at 12 weeks

  • Change from baseline in blood pressure (BP) at 12 weeks

    Post-intervention at 12 weeks

  • Change from baseline in glycated hemoglobin (HbA1C) at 12 weeks

    Post-intervention at 12 weeks

  • +6 more secondary outcomes

Study Arms (2)

PATH Treatment Group

EXPERIMENTAL

The PATH group will be granted password protected access to one of the 3 PATH levels based on their baseline fitness status. The intervention is designed to help participants increase their baseline PA via health coaching, self-monitoring and pragmatic workout videos that provide convenient options for overcoming socio-environmental barriers to PA.

Behavioral: The Physical Activity for The Heart (PATH) intervention

Wait-list control group

ACTIVE COMPARATOR

Participants in this group will not have access to the PATH intervention until after 12 weeks when they cross over. After randomization, the control group will be provided with a copy of the Be Active Your Way booklet, developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives.

Behavioral: Be Active Your Way Booklet

Interventions

The web-based Physical Activity for The Heart (PATH) intervention leverages openly accessible platforms, such as YouTube, to proffer workout videos that match the participants preferences. Currently, PATH includes over 90 workout videos vetted by a team of experts and curated on the PATH website in 3 controlled levels of intensity (beginner, intermediate, proficient) to foster gradual progression from low to high intensity PA in accordance with the FITT-VP (frequency, intensity, time, type, volume, progression) principle.

PATH Treatment Group

Be Active Your Way booklet was developed by the Centers for Disease Control (CDC) to help individuals integrate PA in their daily lives. It simply encourages individuals to increase their PA gradually and gives them examples of things that they can do.

Wait-list control group

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • BMI≥25
  • Have regular access to the internet (via computer or smart phone)
  • Less than 90 mins of self-reported moderate to vigorous physical activity per week
  • American Diabetes Association (ADA) risk ≥5
  • Available for pre and post-intervention assessments.

You may not qualify if:

  • Unstable conditions that may require supervised PA
  • Physical limitations that may prohibit engagement in MVPA
  • Pregnancy or intention to become pregnant during study, history of CVD
  • Current participation in a PA study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Primay Health Network

Beaver Falls, Pennsylvania, 15010, United States

Location

University of Pittsburgh

Pittsburgh, Pennsylvania, 15261, United States

Location

Related Publications (1)

  • Kariuki JK, Sereika S, Erickson K, Burke LE, Kriska A, Cheng J, Milton H, Hirshfield S, Ogutu D, Gibbs B. Feasibility and preliminary efficacy of a novel web-based physical activity intervention in adults with overweight/obesity: A pilot randomized controlled trial. Contemp Clin Trials. 2023 Oct;133:107318. doi: 10.1016/j.cct.2023.107318. Epub 2023 Aug 23.

MeSH Terms

Conditions

Prediabetic StateOverweightObesitySedentary BehaviorMotor Activity

Interventions

Methods

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Jacob Kariuki, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: We will randomize 52 participants to either the PATH treatment group or wait-list control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

November 2, 2020

First Posted

November 9, 2020

Study Start

October 27, 2020

Primary Completion

March 12, 2022

Study Completion

March 12, 2022

Last Updated

October 7, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

t is our goal to make all data generated from this proposal available to other investigators without compromising the confidentiality of participants. Investigators who would like to do a secondary analysis of de-identified data can submit a formal request for the data including the proposal of their intended analysis to the PI at activeu@pitt.edu. The PI will review all requests and facilitate data access once approval is granted.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
12 months after the end of the study
Access Criteria
Data access will be provided based on scientific merit of the proposed analysis, IRB approval and data agreement contract as deemed appropriate by University of Pittsburgh

Locations